1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Clinical Chemistry Analyzer Market by Product (Systems & Reagents), Test Type (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals), End User (Hospitals, Laboratories, Academic Research) - Global Forecast to 2019

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global clinical chemistry analyzers market and its subsegments. Secondary information was used to identify the overall revenues, geographic reach, and product portfolios of the market players. Estimates of their clinical chemistry analyzers segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each subsegment and the relative differences in the growth rates.

The global clinical chemistry analyzers market report segments this market on the basis of products, test, end users and regions. The clinical chemistry analyzers segment is further divided into four subsegments, Small (400-800 Test/H), Medium (800-1,200 Tests/H), Large (1,200-2,000 Tests/H), and Very large (2,000 Tests/H). The reagent segment is categorized into calibrators, controls, standards and other reagents. The test segments included in this report are basic metabolic panel, electrolyte panel, liver panel, lipid profile, renal profile/kidney function panel, thyroid function panel, specialty chemical tests.

The geographic segments included in this report are Americas, Europe, BRIC, Japan and Rest of the World (RoW). The geographic analysis reveals that Americas accounted for the largest share in the global clinical chemistry analyzers market in 2014. The BRIC regional segment, on the other hand, is expected to register a faster growth from 2014 to 2019, due to the increasing demand for automation from this region.

The key drivers for this market are rise in number of lifestyle diseases; automation of laboratories will aid the growth of this market. Increasing awareness for preventative care, increase in aging population, increase in reagent rental agreements and laboratory automation will drive the demand for clinical chemistry analyzers products. Growth in the clinical chemistry market will drive the growth of the clinical chemistry analyzers market.

The report provides qualitative insights about key market shares, growth rates, and market drivers for all important subsegments. It maps the market sizes and growth rates of each subsegment and identifies the segments poised for rapid growth in each of the geographic segments. The report also includes company profiles of the market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the clinical chemistry analyzers market. The competitive landscape covers the growth strategies adopted by the industry players over the last three years. It also includes analysis of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:

• Product Development/Innovation: Product portfolios of the top players in the clinical chemistry analyzers market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the clinical chemistry analyzers market
• Competitive Assessment: In-depth assessment of the market shares, strategies, geographic and business segments, and product portfolios of the leading players in the clinical chemistry analyzers market
• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various clinical chemistry analyzers products across geographies.
• Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the clinical chemistry analyzers market.

Table Of Contents

Clinical Chemistry Analyzer Market by Product (Systems and Reagents), Test Type (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals), End User (Hospitals, Laboratories, Academic Research) - Global Forecast to 2019
1 INTRODUCTION 18

1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET SCOPE 19
1.2.1 MARKETS COVERED 20
1.3 STAKEHOLDERS 21

2 RESEARCH METHODOLOGY 22

2.1 MARKET SIZE ESTIMATION 23
2.2 MARKET CRACKDOWN AND DATA TRIANGULATION 25
2.3 MARKET SHARE ESTIMATION 26
2.3.1 KEY DATA FROM SECONDARY SOURCES 26
2.3.2 KEY DATA FROM PRIMARY SOURCES 27
2.3.2.1 Key Industry Insights 27
2.3.3 ASSUMPTIONS 28

3 EXECUTIVE SUMMARY 29

4 PREMIUM INSIGHTS 32

4.1 CLINICAL CHEMISTRY ANALYZERS MARKET TO GROW AT A MODEST RATE 32
4.2 LIFE CYCLE ANALYSIS, BY REGION 33

5 MARKET OVERVIEW 35

5.1 INTRODUCTION 36
5.2 MARKET SEGMENTATION 36
5.2.1 CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT 36
5.2.2 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST 36
5.2.3 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER 37
5.3 MARKET DYNAMICS 37
5.3.1 DRIVERS 38
5.3.1.1 Increasing healthcare expenditure 38
5.3.1.2 Rapidly aging population is an important indirect driver for this market 39
5.3.1.3 Increasing prevalence of lifestyle diseases 40
5.3.1.4 Increase in laboratory automation 40
5.3.1.5 Rise in the number of reagent rental agreements 40
5.3.1.6 Increase in access to medical insurance in the U.S. market 40
5.3.2 RESTRAINTS 41
5.3.2.1 Requirement of high capital investments 41
5.3.2.2 Stringent regulatory policies for medical devices 41
5.3.2.3 High degree of consolidation to act as an entry barrier for new entrants 41
5.3.3 OPPORTUNITIES 41
5.3.3.1 Growing opportunities in emerging economies 41
5.3.4 TRENDS 42
5.3.4.1 Quick turnaround times 42
5.3.4.2 High throughput 42
5.3.4.3 Demand for modular automation 42

6 INDUSTRY INSIGHTS 43

6.1 INTRODUCTION 43
6.2 PORTER'S FIVE FORCES ANALYSIS 43
6.2.1 THREAT FROM NEW ENTRANTS 44
6.2.2 THREAT FROM SUBSTITUTES 44
6.2.3 BARGAINING POWER OF BUYERS 44
6.2.4 BARGAINING POWER OF SUPPLIERS 44
6.2.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 44
6.3 STRATEGIC BENCHMARKING 45
6.3.1 NEW PRODUCT LAUNCHES 45
6.4 SUPPLY CHAIN ANALYSIS 46
6.4.1 KEY INFLUENCERS 47

7 CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT 48

7.1 INTRODUCTION 49
7.2 ANALYZERS 50
7.3 REAGENTS 53
7.4 OTHER PRODUCTS 55

8 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST 56

8.1 INTRODUCTION 57
8.2 BASIC METABOLIC PANELS 58
8.3 ELECTROLYTE PANELS 60
8.4 LIVER PANELS 61
8.5 LIPID PROFILES 62
8.6 RENAL PROFILES 64
8.7 THYROID FUNCTION PANELS 66
8.8 SPECIALTY CHEMICAL TESTS 67

9 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USERS 68

9.1 INTRODUCTION 69
9.2 ACADEMIC RESEARCH CENTERS 70
9.3 DIAGNOSTIC LABORATORIES 71
9.4 HOSPITALS 72
9.5 OTHER END USERS 73

10 GEOGRAPHIC ANALYSIS 75

10.1 INTRODUCTION 76
10.2 THE AMERICAS 79
10.2.1 CANADA 86
10.2.2 CHILE 89
10.2.3 MEXICO 92
10.2.4 U.S. 95
10.2.5 REST OF THE AMERICAS (ROA) 98
10.3 BRIC 101
10.3.1 BRAZIL 107
10.3.2 CHINA 110
10.3.3 INDIA 113
10.3.4 RUSSIA 116
10.4 EUROPE 119
10.4.1 FRANCE 126
10.4.2 GERMANY 129
10.4.3 ITALY 132
10.4.4 SPAIN 135
10.4.5 U.K. 138
10.4.6 REST OF EUROPE (ROE) 141
10.5 JAPAN 144
10.6 REST OF THE WORLD (ROW) 149

11 COMPETITIVE LANDSCAPE 154

11.1 INTRODUCTION 154
11.2 MARKET SHARE ANALYSIS: CLINICAL CHEMISTRY ANALYZERS MARKET 155
11.3 COMPETITIVE SITUATION AND TRENDS 157
11.3.1 NEW PRODUCT LAUNCHES 157
11.3.2 ACQUISITIONS 158
11.3.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 159
11.3.4 EXPANSIONS 160
11.3.5 OTHER DEVELOPMENTS 161

12 COMPANY PROFILES 162

12.1 INTRODUCTION 162
12.2 ABBOTT LABORATORIES 163
12.3 DANAHER CORPORATION 166
12.4 F. HOFFMANN-LA ROCHE LTD. 169
12.5 JOHNSON and JOHNSON 173
12.6 SIEMENS AG 176
12.7 ELITECH GROUP 179
12.8 HORIBA, LTD. 180
12.9 MINDRAY MEDICAL INTERNATIONAL LIMITED 183
12.10 RANDOX LABORATORIES LTD. 186
12.11 THERMO FISHER SCIENTIFIC INC. 188
*Details On Financials, Products and Services, Key Strategy, and Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

13 APPENDIX 190

13.1 INSIGHTS OF INDUSTRY EXPERTS 190
13.2 DISCUSSION GUIDE 190
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 192
13.4 AVAILABLE CUSTOMIZATIONS 194
13.5 RELATED REPORTS 194

LIST OF TABLES

TABLE 1 MARKET DEVELOPMENTS BETWEEN 2011 AND 2014 45
TABLE 2 GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 50
TABLE 3 CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 52
TABLE 4 CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 53
TABLE 5 CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY TEST,
2012-2019 ($MILLION) 58
TABLE 6 BASIC METABOLIC PANEL TESTS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 59
TABLE 7 ELECTROLYTE PANEL TESTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 60
TABLE 8 LIVER PANEL TESTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 62
TABLE 9 LIPID PROFILE TESTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 64
TABLE 10 RENAL PROFILE TESTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 65
TABLE 11 THYROID FUNCTION PANEL TESTS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 66
TABLE 12 SPECIALTY CHEMICAL TESTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 67
TABLE 13 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER,
2012-2019 ($MILLION) 70
TABLE 14 GLOBAL CLINICAL CHEMISTRY MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2012-2019 ($MILLION) 71
TABLE 15 CLINICAL CHEMISTRY ANALYZERS MARKET FOR DIAGNOSTIC LABORATORIES,
BY REGION, 2012-2019 ($MILLION) 72
TABLE 16 GLOBAL CLINICAL CHEMISTRY MARKET FOR HOSPITALS, BY REGION,
2012-2019 ($MILLION) 73
TABLE 17 GLOBAL CLINICAL CHEMISTRY MARKET FOR OTHER END USERS, BY REGION, 2012-2019 ($MILLION) 74
TABLE 18 CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 78
TABLE 19 THE AMERICAS: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 81
TABLE 20 THE AMERICAS: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 82
TABLE 21 THE AMERICAS: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012-2019 ($MILLION) 83
TABLE 22 THE AMERICAS: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY TEST,
2012-2019 ($MILLION) 84
TABLE 23 THE AMERICAS: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 85
TABLE 24 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 87
TABLE 25 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 88
TABLE 26 CHILE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 90
TABLE 27 CHILE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 91
TABLE 28 MEXICO: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 93
TABLE 29 MEXICO: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 94
TABLE 30 U.S.: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 96
TABLE 31 U.S.: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 97
TABLE 32 ROA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 99
TABLE 33 ROA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 100
TABLE 34 BRIC: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 102
TABLE 35 BRIC: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 103
TABLE 36 BRIC: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 104
TABLE 37 BRIC: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY TEST,
2012-2019 ($MILLION) 105
TABLE 38 BRIC: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 106
TABLE 39 BRAZIL: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 108
TABLE 40 BRAZIL: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 109
TABLE 41 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 111
TABLE 42 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 112
TABLE 43 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 114
TABLE 44 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 115
TABLE 45 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 117
TABLE 46 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 118
TABLE 47 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 121
TABLE 48 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 122
TABLE 49 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 123
TABLE 50 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY TEST,
2012-2019 ($MILLION) 124
TABLE 51 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 125
TABLE 52 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 127
TABLE 53 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 128
TABLE 54 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 130
TABLE 55 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 131
TABLE 56 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 133
TABLE 57 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 134
TABLE 58 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 136
TABLE 59 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 137
TABLE 60 U.K.: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 139
TABLE 61 U.K.: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 140
TABLE 62 ROE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 142
TABLE 63 ROE: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 143
TABLE 64 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 145
TABLE 65 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 146
TABLE 66 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY TEST,
2012-2019 ($MILLION) 147
TABLE 67 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 148
TABLE 68 ROW: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 150
TABLE 69 ROW: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY,
2012-2019 ($MILLION) 151
TABLE 70 ROW: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY TEST,
2012-2019 ($MILLION) 152
TABLE 71 ROW: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 153
TABLE 72 NEW PRODUCT LAUNCHES, 2011-2014 157
TABLE 73 ACQUISITIONS, 2011-2014 158
TABLE 74 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2011-2014 159
TABLE 75 EXPANSIONS, 2011-2014 160
TABLE 76 OTHER DEVELOPMENTS, 2011-2014 161

LIST OF FIGURES

FIGURE 1 GLOBAL CLINICAL CHEMISTRY ANALYZERS MARKET 20
FIGURE 2 RESEARCH METHODOLOGY 22
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 24
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 24
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 25
FIGURE 6 DATA TRIANGULATION METHODOLOGY 26
FIGURE 7 REAGENTS IS THE LARGEST AND FASTEST-GROWING PRODUCT SEGMENT 29
FIGURE 8 BASIC METABOLIC PANEL IS THE LARGEST TEST SEGMENT IN 2014 30
FIGURE 9 HOSPITALS WILL DOMINATE THE CLINICAL CHEMISTRY ANALYZERS MARKET
BY 2019 30
FIGURE 10 BRIC IS THE FASTEST-GROWING REGION IN THE CLINICAL CHEMISTRY ANALYZERS MARKET 31
FIGURE 11 INCREASING HEALTHCARE EXPENDITURE AND RISING DEMAND FROM BRIC ARE IMPORTANT GROWTH DRIVERS 32
FIGURE 12 REAGENTS TO ACCOUNT FOR THE MAXIMUM MARKET SHARE IN THE CLINICAL CHEMISTRY ANALYZERS MARKET 32
FIGURE 13 BRIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 33
FIGURE 14 BRIC MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES 33
FIGURE 15 MARKET SEGMENTATION: BY PRODUCT 36
FIGURE 16 MARKET SEGMENTATION: BY TEST 37
FIGURE 17 MARKET SEGMENTATION: BY END USER 37
FIGURE 18 INCREASE IN HEALTHCARE EXPENDITURE WILL BE THE PRIMARY GROWTH DRIVER IN THIS MARKET 38
FIGURE 19 INCREASING HEALTHCARE EXPENDITURE IS THE MOST IMPORTANT DRIVER FOR THE CLINICAL CHEMISTRY ANALYZERS MARKET 39
FIGURE 20 POPULATION OF PEOPLE OVER 65 YEARS IS INCREASING AT CLOSE TO TWICE THE RATE OF THE GENERAL POPULATION 39
FIGURE 21 GROWTH IN HEALTHCARE EXPENDITURE IN BRIC AND ROW OUTPACING THAT IN AMERICAS AND EUROPE 42
FIGURE 22 PORTER'S FIVE FORCES ANALYSIS 43
FIGURE 23 MOST MARKET PLAYERS ADOPTED ORGANIC GROWTH STRATEGY OF NEW PRODUCT LAUNCHES BETWEEN 2011 AND 2014 46
FIGURE 24 SUPPLY CHAIN ANALYSIS 47
FIGURE 25 CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT 49
FIGURE 26 GLOBAL CLINICAL CHEMISTRY MARKET SHARE, BY PRODUCT, 2012-2019 49
FIGURE 27 CLINICAL CHEMISTRY ANALYZERS MARKET SEGMENTATION, BY CAPACITY 51
FIGURE 28 CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY CAPACITY, 2012-2019 ($MILLION) 52
FIGURE 29 CLINICAL CHEMISTRY REAGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 54
FIGURE 30 CLINICAL CHEMISTRY REAGENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 54
FIGURE 31 CLINICAL CHEMISTRY OTHER PRODUCTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 55
FIGURE 32 CLINICAL CHEMISTRY OTHER PRODUCTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 55
FIGURE 33 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST 57
FIGURE 34 CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY TEST, 2014 (MARKET SIZE AND GROWTH RATES) 57
FIGURE 35 AMERICAS TO ACCOUNT FOR THE LARGEST SHARE IN THE BASIC METABOLIC PANEL SEGMENT 59
FIGURE 36 AMERICAS TO ACCOUNT FOR THE LARGEST SHARE OF THE ELECTROLYTE PANEL TEST SEGMENT 60
FIGURE 37 BRIC TO GROW AT THE HIGHEST CAGR IN THE LIVER PANEL TESTS MARKET 61
FIGURE 38 INCREASED OBESITY RATES TO AID THE GROWTH OF THE LIPID PROFILE TESTS SEGMENT 63
FIGURE 39 BRIC TO BE THE FASTEST-GROWING MARKET FOR LIPID PROFILE TESTS 63
FIGURE 40 BRIC IS EXPECTED TO BE THE FASTEST-GROWING MARKET FOR RENAL PROFILE TESTS 65
FIGURE 41 AMERICAS IS THE LARGEST MARKET FOR THYROID FUNCTION PANEL TESTS 66
FIGURE 42 AMERICAS ARE THE LARGEST MARKET FOR SPECIALTY CHEMICAL TESTS 67
FIGURE 43 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER 69
FIGURE 44 CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY END USER, 2014 (MARKET SIZE AND GROWTH RATES) 69
FIGURE 45 AMERICA HOLDS LARGEST SHARE OF CLINICAL CHEMISTRY ANALYZERS MARKET FOR ACADEMIC RESEARCH INSTITUTES 70
FIGURE 46 THE AMERICAS HOLDS LARGEST SHARE OF CLINICAL CHEMISTRY ANALYZERS MARKET FOR DIAGNOSTIC LABORATORIES 71
FIGURE 47 BRIC HOSPITALS SEGMENT EXPECTED TO SHOW FASTEST GROWTH IN CLINICAL CHEMISTRY ANALYZERS MARKET 72
FIGURE 48 BRIC REGIONAL SEGMENT SHOWS HIGHEST GROWTH IN CLINICAL CHEMISTRY ANALYZERS MARKET FOR OTHER END USERS 73
FIGURE 49 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION 76
FIGURE 50 GLOBAL ECONOMIC INDICATORS (2003-2012) 77
FIGURE 51 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION (MARKET SIZE AND GROWTH RATE), 2014-2019 78
FIGURE 52 AMERICAS: ECONOMIC INDICATORS (2003-2012) 79
FIGURE 53 AMERICAS: MARKET SNAPSHOT 80
FIGURE 54 AMERICAS: CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION (MARKET SIZE AND GROWTH RATE), 2014-2019 81
FIGURE 55 REAGENTS ARE ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE AMERICAS IN 2014 82
FIGURE 56 THE AMERICAS: MEDIUM-SIZED ANALYZERS TO GROW AT THE HIGHEST CAGR FROM 2014 TO 2019 83
FIGURE 57 THE AMERICAS: CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY TEST (MARKET SIZE AND GROWTH RATE), 2014-2019 84
FIGURE 58 HOSPITALS TO ACCOUNT FOR THE LARGEST SHARE OF THE CLINICAL CHEMISTRY ANALYZERS END-USERS MARKET IN THE AMERICAS 85
FIGURE 59 CANADA: ECONOMIC INDICATORS (2003-2012) 86
FIGURE 60 REAGENTS ARE THE LARGEST AND THE FASTEST-GROWING PRODUCT SEGMENT IN CANADA- 2014-2019 87
FIGURE 61 SMALL-SIZED ANALYZERS TO BE THE FASTEST-GROWING ANALYZERS SEGMENT IN CANADA- 2014-2019 88
FIGURE 62 CHILE: ECONOMIC INDICATORS (2003-2012) 89
FIGURE 63 REAGENTS TO ACCOUNT FOR THE LARGEST SHARE OF THE CLINICAL CHEMISTRY ANALYZERS MARKET IN CHILE- 2014-2019 90
FIGURE 64 CHILE: SMALL-SIZED ANALYZERS TO GROW AT HIGHEST CAGR FROM 2014-2019 91
FIGURE 65 MEXICO: ECONOMIC INDICATORS (2003-2012) 92
FIGURE 66 REAGENTS TO BE THE FASTEST-GROWING PRODUCT SEGMENT IN MEXICO 93
FIGURE 67 MEXICO: SMALL-SIZED ANALYZERS TO WITNESS THE HIGHEST GROWTH 94
FIGURE 68 U.S.: ECONOMIC INDICATORS (2003-2012) 95
FIGURE 69 REAGENTS ARE THE LARGEST PRODUCT SEGMENT IN THE U.S. 96
FIGURE 70 U.S.: MEDIUM-SIZED ANALYZERS TO WITNESS HIGHEST GROWTH 97
FIGURE 71 ROA: ECONOMIC INDICATORS (2003-2012) 98
FIGURE 72 REAGENTS TO BE THE FASTEST-GROWING PRODUCT SEGMENT IN THE ROA 99
FIGURE 73 ROA: SMALL-SIZED ANALYZERS TO GROW AT HIGHEST CAGR 100
FIGURE 74 BRIC: ECONOMIC INDICATORS (2003-2012) 101
FIGURE 75 BRIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY (MARKET SIZE AND GROWTH RATE), 2014-2019 102
FIGURE 76 REAGENTS TO ACCOUNT FOR THE LARGEST SHARE OF THE CLINICAL CHEMISTRY ANALYZERS MARKET IN BRIC IN 2014 103
FIGURE 77 BRIC: SMALL-SIZED ANALYZERS TO WITNESS HIGHEST CAGR 104
FIGURE 78 LIPID PROFILE IS THE FASTEST-GROWING TEST SEGMENT IN BRIC BETWEEN 2014 AND 2019 105
FIGURE 79 HOSPITALS ARE THE LARGEST AND THE FASTEST-GROWING END-USER SEGMENT IN BRIC 106
FIGURE 80 BRAZIL: ECONOMIC INDICATORS (2003-2012) 107
FIGURE 81 BRAZIL: THE REAGENTS SEGMENT TO WITNESS HIGHEST GROWTH 108
FIGURE 82 BRAZIL: SMALL-SIZED ANALYZERS TO GROW AT THE HIGHEST CAGR 109
FIGURE 83 CHINA: ECONOMIC INDICATORS (2003-2012) 110
FIGURE 84 REAGENTS ARE THE LARGEST PRODUCT SEGMENT IN CHINA 111
FIGURE 85 CHINA: SMALL-SIZED ANALYZERS TO GROW AT THE HIGHEST CAGR 112
FIGURE 86 INDIA: ECONOMIC INDICATORS (2003-2012) 113
FIGURE 87 REAGENTS ARE THE LARGEST AND THE FASTEST-GROWING PRODUCT SEGMENT IN INDIA 113
FIGURE 88 INDIA: SMALL-SIZED ANALYZERS TO WITNESS HIGHEST GROWTH 115
FIGURE 89 RUSSIA: ECONOMIC INDICATORS (2003-2012) 116
FIGURE 90 REAGENTS TO BE THE FASTEST-GROWING PRODUCT SEGMENT IN RUSSIA 117
FIGURE 91 SMALL-SIZED ANALYZERS TO BE THE FASTEST-GROWING ANALYZER SEGMENT IN RUSSIA 118
FIGURE 92 EUROPE: ECONOMIC INDICATORS (2003-2012) 119
FIGURE 93 EUROPE: MARKET SNAPSHOT 120
FIGURE 94 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2014-2019 (MARKET SIZE AND GROWTH RATES) 121
FIGURE 95 REAGENTS ARE THE LARGEST REVENUE CONTRIBUTORS TO CLINICAL CHEMISTRY ANALYZERS MARKET IN EUROPE IN 2014 122
FIGURE 96 MEDIUM-SIZED ANALYZERS TO HOLD LARGEST MARKET SHARE IN EUROPE 123
FIGURE 97 LIPID PROFILE TO BE FASTEST-GROWING TEST SEGMENT OF CLINICAL CHEMISTRY ANALYZERS MARKET IN EUROPE 124
FIGURE 98 HOSPITALS TO HOLD LARGEST MARKET SHARE IN EUROPE 125
FIGURE 99 France: ECONOMIC INDICATORS (2003-2012) 126
FIGURE 100 REAGENTS TO WITNESS HIGHEST GROWTH IN France BY 2019 127
FIGURE 101 MEDIUM-SIZED ANALYZERS MARKET TO WITNESS HIGHEST GROWTH 128
FIGURE 102 GERMANY: ECONOMIC INDICATORS (2003-2012) 129
FIGURE 103 REAGENTS TO WITNESS HIGHEST GROWTH RATE IN GERMANY BY 2019 130
FIGURE 104 MEDIUM-SIZED ANALYZERS SEGMENT TO WITNESS HIGHEST GROWTH 131
FIGURE 105 ITALY: ECONOMIC INDICATORS (2003-2012) 132
FIGURE 106 REAGENTS TO WITNESS HIGHEST GROWTH RATE IN ITALY BY 2019 133
FIGURE 107 SMALL-SIZED ANALYZERS TO BE THE FASTEST-GROWING ANALYZERS SEGMENT
IN ITALY 134
FIGURE 108 SPAIN: ECONOMIC INDICATORS (2003-2012) 135
FIGURE 109 REAGENTS TO WITNESS HIGHEST GROWTH RATE IN SPAIN BY 2019 136
FIGURE 110 SMALL-SIZED ANALYZERS TO BE THE FASTEST-GROWING ANALYZERS SEGMENT IN SPAIN 137
FIGURE 111 U.K.: ECONOMIC INDICATORS (2003-2012) 138
FIGURE 112 REAGENTS TO WITNESS HIGHEST GROWTH RATE IN THE U.K. BY 2019 139
FIGURE 113 MEDIUM-SIZED ANALYZERS TO BE THE FASTEST-GROWING ANALYZERS SEGMENT IN THE U.K. 140
FIGURE 114 ROE: ECONOMIC INDICATORS (2003-2012) 141
FIGURE 115 REAGENTS TO WITNESS HIGHEST GROWTH RATE IN ROE BY 2019 142
FIGURE 116 SMALL-SIZED ANALYZERS TO BE FASTEST-GROWING SEGMENT IN ROE 143
FIGURE 117 JAPAN: ECONOMIC INDICATORS (2003-2012) 144
FIGURE 118 REAGENTS ARE ESTIMATED TO COMMAND LARGEST SHARE OF THE TOTAL CLINICAL CHEMISTRY ANALYZERS MARKET IN JAPAN IN 2014 145
FIGURE 119 MEDIUM-SIZED ANALYZERS TO COMMAND LARGEST MARKET SHARE IN JAPAN 146
FIGURE 120 LIPID PROFILES TO BE THE FASTEST-GROWING TEST SEGMENT IN CLINICAL CHEMISTRY ANALYZERS MARKET IN JAPAN 147
FIGURE 121 HOSPITALS TO COMMAND LARGEST SHARE OF END-USER MARKET IN JAPAN 148
FIGURE 122 ROW: ECONOMIC INDICATORS (2003-2012) 149
FIGURE 123 REAGENTS COMMAND LARGEST SHARE OF TOTAL CLINICAL CHEMISTRY ANALYZERS MARKET IN THE ROW 150
FIGURE 124 MEDIUM-SIZE ANALYZERS TO HOLD LARGEST SHARE IN EUROPE 151
FIGURE 125 LIPID PROFILES TO BE THE FASTEST-GROWING TEST SEGMENT IN ROW 152
FIGURE 126 HOSPITALS TO COMMAND LARGEST SHARE OF END-USER MARKET IN ROW 153
FIGURE 127 PRODUCT INNOVATIONS IS THE KEY STRATEGY ADOPTED BY PLAYERS IN THE CLINICAL CHEMISTRY ANALYZERS MARKET 154
FIGURE 128 GLOBAL CLINICAL CHEMISTRY ANALYZERS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 155
FIGURE 129 NEW PRODUCT LAUNCHES IS THE KEY GROWTH STRATEGY 157
FIGURE 130 GEOGRAPHIC REVENUE MIX OF TOP 5 MARKET PLAYERS 162
FIGURE 131 ABBOTT LABORATORIES: BUSINESS OVERVIEW 163
FIGURE 132 DANAHER CORPORATION: BUSINESS OVERVIEW 166
FIGURE 133 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW 169
FIGURE 134 JOHNSON and JOHNSON: BUSINESS OVERVIEW 173
FIGURE 135 SIEMENS AG: BUSINESS OVERVIEW 176
FIGURE 136 HORIBA, LTD.: BUSINESS OVERVIEW 180
FIGURE 137 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW 183
FIGURE 138 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 188

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Immunodiagnostics 2020: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts for 100 Tests--Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, Special Chemistry, Therapeutic Drug Monitoring (TDM), Tumor Markers

Immunodiagnostics 2020: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts for 100 Tests--Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, Special Chemistry, Therapeutic Drug Monitoring (TDM), Tumor Markers

  • $ 23500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report PDF $37,500, DataPack (500 tables) $23,500. The report is available by geographic region, country, section, market segment, test category, and individual assay. VPGMarketResearch.com new ...

2016 Competing in the Global Clinical Chemistry and Immunodiagnostic Markets

2016 Competing in the Global Clinical Chemistry and Immunodiagnostic Markets

  • $ 21800
  • Industry report
  • October 2016
  • by Venture Planning Group

The new seven-country market intelligence and technology assessment study from VPGMarketResearch.com was designed to help current suppliers and potential market entrants identify and evaluate emerging ...

2016 US Clinical Chemistry and Immunodiagnostic Analyzers and Reagents:  Supplier Shares, Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies

2016 US Clinical Chemistry and Immunodiagnostic Analyzers and Reagents: Supplier Shares, Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7,500. VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.